HUP0003034A2 - Vírusos és mikróbafertőzések, valamint leromlási tünetcsoportok kezelésére alkalmazható gyógyszeradagoló eszközök és eljárások - Google Patents

Vírusos és mikróbafertőzések, valamint leromlási tünetcsoportok kezelésére alkalmazható gyógyszeradagoló eszközök és eljárások

Info

Publication number
HUP0003034A2
HUP0003034A2 HU0003034A HUP0003034A HUP0003034A2 HU P0003034 A2 HUP0003034 A2 HU P0003034A2 HU 0003034 A HU0003034 A HU 0003034A HU P0003034 A HUP0003034 A HU P0003034A HU P0003034 A2 HUP0003034 A2 HU P0003034A2
Authority
HU
Hungary
Prior art keywords
treatment
viral
methods
drug delivery
delivery devices
Prior art date
Application number
HU0003034A
Other languages
English (en)
Hungarian (hu)
Inventor
Michelle Olga Patricia Giesteira Visser
Original Assignee
Virodene Pharmaceutical Holdings (Proprietary) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Virodene Pharmaceutical Holdings (Proprietary) Limited filed Critical Virodene Pharmaceutical Holdings (Proprietary) Limited
Publication of HUP0003034A2 publication Critical patent/HUP0003034A2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HU0003034A 1997-06-13 1998-06-09 Vírusos és mikróbafertőzések, valamint leromlási tünetcsoportok kezelésére alkalmazható gyógyszeradagoló eszközök és eljárások HUP0003034A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
HUP0003034A2 true HUP0003034A2 (hu) 2000-12-28

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003034A HUP0003034A2 (hu) 1997-06-13 1998-06-09 Vírusos és mikróbafertőzések, valamint leromlási tünetcsoportok kezelésére alkalmazható gyógyszeradagoló eszközök és eljárások

Country Status (34)

Country Link
EP (1) EP1011567A4 (ko)
JP (1) JP4531141B2 (ko)
KR (1) KR20010013709A (ko)
CN (1) CN1260703A (ko)
AP (1) AP1629A (ko)
AR (1) AR012970A1 (ko)
AU (1) AU7831598A (ko)
BG (1) BG103997A (ko)
BR (1) BR9810095A (ko)
CA (1) CA2295176A1 (ko)
CZ (1) CZ298510B6 (ko)
EA (1) EA200000011A1 (ko)
EE (1) EE9900562A (ko)
ES (1) ES2161187B1 (ko)
FI (1) FI19992648A (ko)
GB (1) GB2341319B (ko)
HU (1) HUP0003034A2 (ko)
ID (1) ID23516A (ko)
IL (2) IL133396A0 (ko)
IS (1) IS5289A (ko)
LT (1) LT4714B (ko)
LV (1) LV12490B (ko)
NO (1) NO996117L (ko)
NZ (1) NZ501669A (ko)
OA (1) OA11307A (ko)
PL (1) PL196256B1 (ko)
RO (1) RO121252B1 (ko)
SI (1) SI20191A (ko)
SK (1) SK172299A3 (ko)
TN (1) TNSN98086A1 (ko)
TR (1) TR200000540T2 (ko)
WO (1) WO1998056325A1 (ko)
YU (1) YU66099A (ko)
ZA (1) ZA984649B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
SI9620126A (sl) * 1995-12-15 1999-10-31 Cryopreservation Technologies Cc (Za/Za) Spojina za kriogensko ohranjanje organov in zdravljenje virusnih ter bakterijskih infekcij

Also Published As

Publication number Publication date
YU66099A (sh) 2002-10-18
GB2341319B (en) 2002-02-27
KR20010013709A (ko) 2001-02-26
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
LT4714B (lt) 2000-10-25
CN1260703A (zh) 2000-07-19
ES2161187A1 (es) 2001-11-16
WO1998056325A1 (en) 1998-12-17
PL338439A1 (en) 2000-11-06
IL133396A0 (en) 2001-04-30
TR200000540T2 (tr) 2000-09-21
IS5289A (is) 1999-12-08
CZ9904473A3 (cs) 2001-03-14
NZ501669A (en) 2001-09-28
CA2295176A1 (en) 1998-12-17
NO996117D0 (no) 1999-12-10
IL133396A (en) 2006-10-05
AP9901708A0 (en) 1999-12-31
ZA984649B (en) 1999-12-17
TNSN98086A1 (fr) 2005-03-15
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
EA200000011A1 (ru) 2000-08-28
NO996117L (no) 2000-02-11
AR012970A1 (es) 2000-11-22
JP4531141B2 (ja) 2010-08-25
ES2161187B1 (es) 2003-08-16
SI20191A (sl) 2000-10-31
GB9929189D0 (en) 2000-02-02
EE9900562A (et) 2000-06-15
AP1629A (en) 2006-07-11
EP1011567A1 (en) 2000-06-28
LV12490B (en) 2000-12-20
EP1011567A4 (en) 2000-06-28
AU7831598A (en) 1998-12-30
JP2002511862A (ja) 2002-04-16
BG103997A (en) 2001-07-31
CZ298510B6 (cs) 2007-10-24
SK172299A3 (en) 2000-09-12
GB2341319A (en) 2000-03-15
FI19992648A (fi) 2000-02-03
LV12490A (en) 2000-06-20
ID23516A (id) 2000-04-27
BR9810095A (pt) 2001-11-13

Similar Documents

Publication Publication Date Title
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DK0585681T3 (da) Anvendelse af IL-4-receptoren til behandling, forebyggelse og diagnose af infektionssygdomme
DE69915458D1 (de) Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
AR021876A1 (es) Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
DE60227389D1 (de) Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
ATE481135T1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
DK1057828T3 (da) Orale trovafloxacin-suspensioner
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
MA27474A1 (fr) Vaccin
AP9801286A0 (en) Therapeutic compounds.
AR022116A1 (es) Terapia de combinacion para el vhc por induccion de ribavirina - interferon alfa
HUP0003034A2 (hu) Vírusos és mikróbafertőzések, valamint leromlási tünetcsoportok kezelésére alkalmazható gyógyszeradagoló eszközök és eljárások
DK82892D0 (da) Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE69231465D1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
TH64256A3 (th) องค์ประกอบของโปรตีนที่ถูกทำให้เสถียร
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
RU2002129950A (ru) Способ профилактики и лечения бруцеллеза